Status:
COMPLETED
Evaluate the Outcomes of Ferric Carboxymaltose in Patients With Perioperative Anemia
Lead Sponsor:
Hospital Universitario Infanta Cristina
Conditions:
Anemia
Anemia (Iron-Loading)
Eligibility:
All Genders
18+ years
Brief Summary
The prevalence of preoperative anaemia in patients undergoing major surgery is approximately 30%, and is independently associated with higher mortality, a higher rate of postoperative complications, a...
Detailed Description
It was conducted a prospective pre-post interventional study between 1 January 2019 and 31 December 2022 at Infanta Cristina University Hospital in Parla (Madrid, Spain). Written informed consent was...
Eligibility Criteria
Inclusion
- Age over 18 years; on the SWL.
- Hemoglobine \<13g/dL.
- Referred for major elective surgery requiring hospital admission (e.g., oncologic resections such as mastectomy, colon resection, nephrectomy, hysterectomy), typically involving general anesthesia and moderate to high morbidity risk, capable of understanding and consenting to the study
- Physically and mentally able to complete assessments
Exclusion
- Patients with hypersensitivity to FC, or any of its excipients. • Patients with active bleeding
Key Trial Info
Start Date :
January 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2024
Estimated Enrollment :
152 Patients enrolled
Trial Details
Trial ID
NCT06948864
Start Date
January 1 2020
End Date
December 31 2024
Last Update
May 2 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Universitario Infanta Cristina
Parla, Madrid, Spain, 28981